Products

Primary tabs

Export products to Excel

Displaying 181 - 195 of 213
Product Alternative Name Development Status Target Mode Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
TDF + LNG Vaginal Ring Tenofovir Disoproxil Fumarate (TDF) +Levonorgestrel Vaginal Ring Active Development Female Hormonal levonorgestrel, tenofivir disoproxil fumarate (TDF) Vaginal Ring Short-acting Phase I Albert Einstein College of Medicine, NIAID, Northwestern University 07/12/2016
Testicular heat Testicular heat supplementation Inactive Male Non-hormonal Testicular Long-acting Phase II University of California at Los Angeles 05/30/2018
Testicular Ultrasound Inactive Male Non-hormonal Testicular Permanent, Long-acting Pre-clinical Parsemus Foundation, University of Bari, University of California, University of North Carolina at Chapel Hill 05/30/2018
Testis-expressed gene 14 (TEX14) Male Non-hormonal TBD TBD Target ID/Validation Baylor College of Medicine, NICHD 05/30/2018
Testosterone undecanoate (TU) TU, Aveed Inactive Male Hormonal testosterone undecanoate Injectable Short-acting Phase III Bayer HealthCare, National Research Institute for Family Planning in Beijing 05/30/2018
Teva DMPA TV-46046 Active Development Female Hormonal medroxyprogesterone acetate Injectable Long-acting Phase I Teva Branded Pharmaceutical Products R&D, Inc. 05/30/2018
TFV + LNG Vaginal Ring Tenofovir (TFV) and levonorgestrel (LNG) ring Active Development Female Hormonal levonorgestrel, tenofovir Vaginal Ring Long-acting Phase I CONRAD 05/30/2018
The Instant Male Pill Clean Sheets Pill, Inhibition of Vas Propulsive Contractility Active Development Male Non-hormonal Oral Short-acting Pre-clinical King's College, London 05/30/2018
Tianjin IUD IUD HBCu375/MCu375 and TCu380A Limited Market Approval Female Non-hormonal copper Intrauterine Long-acting Marketed Tianjin Medical Instrument Factory 05/30/2018
TO-U Tubal Occlusion via Ultrasound Active Development Female Non-hormonal Intrauterine Permanent Pre-clinical FHI 360 05/30/2018
Transcervical Polymer RISUG for women RISUG in the Fallopian Tube Female Non-hormonal Fallopian Tube Permanent, Long-acting Indian Institute of Technology, Kharagpur 05/30/2018
Triclofem DMPA Triclovera, OSKB -1 Limited Market Approval Female Hormonal medroxyprogesterone acetate Injectable Long-acting Marketed PT. Tunggal Idaman Abdi 10/08/2015
Tripterygium Wilfordii Tripterygium wilfordii derivatives, including triptolide Inactive Male Non-hormonal WHO, University of California at Los Angeles 05/30/2018
TU + ENG Testosterone undecanoate (TU) + etonogestrel (ENG) Inactive Male Hormonal testosterone undecanoate, etonogestrel Injectable, Subdermal Long-acting Phase II Organon 07/25/2016
TU + NET-EN Testosterone undecanoate (TU) + norethisterone enanthate (NET-EN Inactive Male Hormonal testosterone undecanoate, norethisterone enanthate Injectable Long-acting Phase II Bayer HealthCare, CONRAD, WHO 05/30/2018
Export to Excel